Suppr超能文献

基于透明质酸的丝胶基 mucoadhesive 自纳米乳药物传递系统(SNEDDS)的制备与评价及其作为靶向乳腺癌的他莫昔芬载体。

Formulation and evaluation of hyaluronic acid-based mucoadhesive self nanoemulsifying drug delivery system (SNEDDS) of tamoxifen for targeting breast cancer.

机构信息

Department of Pharmacy, Quaid-I-Azam University, Islamabad 44000, Pakistan; Department of Pharmacy, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad 45320, Pakistan.

Department of Pharmacy, Quaid-I-Azam University, Islamabad 44000, Pakistan; Department of Pharmacy, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad 45320, Pakistan.

出版信息

Int J Biol Macromol. 2020 Jun 1;152:503-515. doi: 10.1016/j.ijbiomac.2020.02.275. Epub 2020 Feb 26.

Abstract

The present study was intended to develop a papain grafted S-protected hyaluronic acid-lithocholic acid co-block (PAP-HA-ss-LCA) polymeric excipient as an amphiphilic muco permeating stabilizer for targeting breast cancer epithelial cells overexpressed with CD44 receptors. The mucopermeating, stabilizing and targeting capability of the PAP-HA-ss-LCA polymeric excipient was investigated by manufacturing tamoxifen (TMX) loaded self-nanoemulsifying drug delivery system (SNEDDS). TMX loaded PAP-HA-ss-LCA incorporated SNEDDS (TMX-PAP-HA-ss-LCA SNEDDS) were characterized for their surface chemistry, drug release, permeation enhancement, biocompatibility and antitumor activity. FTIR spectroscopic analysis showed successful synthesis of PAP-HA-ss-LCA polymer. X-ray diffraction (XRD) showed the amorphous form of TMX inside SNEDDS. The observed hydrodynamic diameter of TMX-PAP-HA-ss-LCA SNEDDS was 367.5 nm. Furthermore, Hyaluronic Acid-based Mucoadhesive Self Nanoemulsifying Drug Delivery System (SNEDDS) of TMX showed homogeneity in synthesis with low polydispersity and negative zeta potential due to stabilization with PAP-HA-ss-LCA polymer. The distinct spherical shape of the nanodroplets was evident by transmission electron microscopy (TEM). In vitro release kinetics indicated approximately >80% release within 48 h under sink conditions. Ex-vivo permeation study displayed 7.11-folds higher permeation of TMX by TMX-PAP-HA-ss-LCA in contrast to pure TMX. The biocompatibility study proved that SNEDDS formulation was safe and compatible against macrophages. In vitro cytotoxicity studies demonstrated that TMX-PAP-HA-ss-LCA SNEDDS could efficiently kill MCF-7 breast cancer cells as compared to the native TMX drug. Systemic toxicity studies proved the non-toxic nature of TMX-PAP-HA-ss-LCA in contrast to pure TMX. Based on these evidences, TMX-PAP-HA-ss-LCA SNEDDS formulation seems to be promising mucopermeating, augmented intracellular uptake with strong targeting potential for anti-proliferative activity.

摘要

本研究旨在开发一种木瓜蛋白酶接枝 S 保护透明质酸-石胆酸共嵌段(PAP-HA-ss-LCA)聚合物赋形剂,作为一种两亲性黏膜渗透稳定剂,用于靶向过度表达 CD44 受体的乳腺癌上皮细胞。通过制备他莫昔芬(TMX)负载自微乳化给药系统(SNEDDS),研究了 PAP-HA-ss-LCA 聚合物赋形剂的黏膜渗透、稳定和靶向能力。对 TMX 负载 PAP-HA-ss-LCA 共包封的自微乳化给药系统(TMX-PAP-HA-ss-LCA SNEDDS)进行了表面化学、药物释放、渗透增强、生物相容性和抗肿瘤活性的表征。傅里叶变换红外光谱(FTIR)分析表明成功合成了 PAP-HA-ss-LCA 聚合物。X 射线衍射(XRD)表明 TMX 在 SNEDDS 中呈无定形形式。TMX-PAP-HA-ss-LCA SNEDDS 的观察到的水动力学直径为 367.5nm。此外,基于透明质酸的黏膜黏附自微乳状液药物传递系统(SNEDDS)的 TMX 显示出合成均匀性,具有低多分散性和负 zeta 电位,因为其与 PAP-HA-ss-LCA 聚合物稳定化。通过透射电子显微镜(TEM)可以明显看出纳米液滴的明显球形形状。体外释放动力学表明,在 48 小时内在水槽条件下释放超过 80%。体外渗透研究显示,与纯 TMX 相比,TMX-PAP-HA-ss-LCA 中 TMX 的渗透增加了 7.11 倍。生物相容性研究证明 SNEDDS 配方是安全且与巨噬细胞相容的。体外细胞毒性研究表明,与天然 TMX 药物相比,TMX-PAP-HA-ss-LCA SNEDDS 能够有效杀死 MCF-7 乳腺癌细胞。系统毒性研究证明了 TMX-PAP-HA-ss-LCA 与纯 TMX 相比具有非毒性。基于这些证据,TMX-PAP-HA-ss-LCA SNEDDS 制剂似乎具有有前途的黏膜渗透、增强细胞内摄取以及针对增殖活性的强靶向潜力。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验